These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 27712639)

  • 1. Antithrombotic Approaches in Acute Coronary Syndromes: Optimizing Benefit vs Bleeding Risks.
    Singh M; Bhatt DL; Stone GW; Rihal CS; Gersh BJ; Lennon RJ; Narula J; Fuster V
    Mayo Clin Proc; 2016 Oct; 91(10):1413-1447. PubMed ID: 27712639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet and antithrombin strategies in acute coronary syndrome: state-of-the-art review.
    Showkathali R; Natarajan A
    Curr Cardiol Rev; 2012 Aug; 8(3):239-49. PubMed ID: 22935021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study.
    Cuisset T; Deharo P; Quilici J; Johnson TW; Deffarges S; Bassez C; Bonnet G; Fourcade L; Mouret JP; Lambert M; Verdier V; Morange PE; Alessi MC; Bonnet JL
    Eur Heart J; 2017 Nov; 38(41):3070-3078. PubMed ID: 28510646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clopidogrel instead of prasugrel or ticagrelor after 1 month in stabilized ACS patients: back to square one for DAPT?
    Sinnaeve PR; Van de Werf F
    Eur Heart J; 2017 Nov; 38(41):3079-3081. PubMed ID: 28510709
    [No Abstract]   [Full Text] [Related]  

  • 5. [Management of the bleeding risk associated with antiplatelet agents].
    Martin AC; Houssany-Pissot S; Zlotnik D; Taylor G; Godier A
    Rev Med Interne; 2017 Jul; 38(7):467-473. PubMed ID: 28528236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRotective Effect on the coronary microcirculation of patients with DIabetes by Clopidogrel or Ticagrelor (PREDICT): study rationale and design. A randomized multicenter clinical trial using intracoronary multimodal physiology.
    Cerrato E; Quirós A; Echavarría-Pinto M; Mejia-Renteria H; Aldazabal A; Ryan N; Gonzalo N; Jimenez-Quevedo P; Nombela-Franco L; Salinas P; Núñez-Gil IJ; Rumoroso JR; Fernández-Ortiz A; Macaya C; Escaned J
    Cardiovasc Diabetol; 2017 May; 16(1):68. PubMed ID: 28526024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and Management of Geographic Disparities in the TOPCAT Trial: Lessons Learned and Derivative Recommendations.
    Bristow MR; Enciso JS; Gersh BJ; Grady C; Rice MM; Singh S; Sopko G; Boineau R; Rosenberg Y; Greenberg BH
    JACC Basic Transl Sci; 2016 Apr; 1(3):180-189. PubMed ID: 27747305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association Between Rate and Severity of Exacerbations in Chronic Obstructive Pulmonary Disease: An Application of a Joint Frailty-Logistic Model.
    Sadatsafavi M; Sin DD; Zafari Z; Criner G; Connett JE; Lazarus S; Han M; Martinez F; Albert R
    Am J Epidemiol; 2016 Nov; 184(9):681-689. PubMed ID: 27737842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No Association of Coronary Artery Disease with X-Chromosomal Variants in Comprehensive International Meta-Analysis.
    Loley C; Alver M; Assimes TL; Bjonnes A; Goel A; Gustafsson S; Hernesniemi J; Hopewell JC; Kanoni S; Kleber ME; Lau KW; Lu Y; Lyytikäinen LP; Nelson CP; Nikpay M; Qu L; Salfati E; Scholz M; Tukiainen T; Willenborg C; Won HH; Zeng L; Zhang W; Anand SS; Beutner F; Bottinger EP; Clarke R; Dedoussis G; Do R; Esko T; Eskola M; Farrall M; Gauguier D; Giedraitis V; Granger CB; Hall AS; Hamsten A; Hazen SL; Huang J; Kähönen M; Kyriakou T; Laaksonen R; Lind L; Lindgren C; Magnusson PK; Marouli E; Mihailov E; Morris AP; Nikus K; Pedersen N; Rallidis L; Salomaa V; Shah SH; Stewart AF; Thompson JR; Zalloua PA; Chambers JC; Collins R; Ingelsson E; Iribarren C; Karhunen PJ; Kooner JS; Lehtimäki T; Loos RJ; März W; McPherson R; Metspalu A; Reilly MP; Ripatti S; Sanghera DK; Thiery J; Watkins H; Deloukas P; Kathiresan S; Samani NJ; Schunkert H; Erdmann J; König IR
    Sci Rep; 2016 Oct; 6():35278. PubMed ID: 27731410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Prasugrel and Ticagrelor in Acute Coronary Syndrome. Results of a "Real World" Multicenter Registry.
    Almendro-Delia M; García-Alcántara Á; de la Torre-Prados MV; Reina-Toral A; Arboleda-Sánchez JA; Butrón-Calderón M; García-Guerrero A; de la Chica-Ruiz Ruano R; Hidalgo-Urbano R; García-Rubira JC
    Rev Esp Cardiol (Engl Ed); 2017 Nov; 70(11):952-959. PubMed ID: 28576388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet and antithrombotic treatment for secondary prevention in ischaemic heart disease.
    Lettino M; Leonardi S; De Maria E; Halvorsen S
    Eur J Prev Cardiol; 2017 Jun; 24(3_suppl):61-70. PubMed ID: 28618904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tailored antiplatelet therapy in high-risk ACS patients treated with PCI stenting: lessons from the ANTARCTIC trial.
    Messas N; Tanguay JF; Lordkipanidzé M
    J Thorac Dis; 2017 May; 9(5):E440-E443. PubMed ID: 28616304
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet inhibition after loading dose of prasugrel in patients with ST-elevation and non-ST-elevation acute coronary syndrome.
    Wakabayashi S; Kitahara H; Nishi T; Sugimoto K; Nakayama T; Fujimoto Y; Ariyoshi N; Kobayashi Y
    Cardiovasc Interv Ther; 2018 Jul; 33(3):239-246. PubMed ID: 28608310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative efficacy and safety of ticagelor vs clopidogrel as a function of time to invasive management in non-ST-segment elevation acute coronary syndrome in the PLATO trial.
    Pollack CV; Davoudi F; Diercks DB; Becker RC; James SK; Lim ST; Schulte PJ; Spinar J; Steg PG; Storey RF; Himmelmann A; Wallentin L; Cannon CP;
    Clin Cardiol; 2017 Jun; 40(6):390-398. PubMed ID: 28598510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS study.
    Baber U; Sartori S; Aquino M; Kini A; Kapadia S; Weiss S; Strauss C; Muhlestein JB; Toma C; Rao SV; DeFranco A; Poddar KL; Chandrasekhar J; Weintraub W; Henry TD; Bansilal S; Baker BA; Marrett E; Keller S; Effron M; Pocock S; Mehran R
    Am Heart J; 2017 Jun; 188():73-81. PubMed ID: 28577683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Long Does It Take for Clopidogrel and Ticagrelor to Inhibit Platelets in Patients Undergoing Primary Percutaneous Coronary Intervention? A Detailed Pharmacodynamic Analysis: Time Course of Platelet Reactivity in STEMI (TOPS).
    Bergmeijer TO; Godschalk TC; Janssen PWA; Berge KVD; Breet NJ; Kelder JC; Hackeng CM; Ten Berg JM
    Semin Thromb Hemost; 2017 Jun; 43(4):439-446. PubMed ID: 28561235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disaggregation Following Agonist-Induced Platelet Activation in Patients on Dual Antiplatelet Therapy.
    Wadowski PP; Eichelberger B; Kopp CW; Pultar J; Seidinger D; Koppensteiner R; Lang IM; Panzer S; Gremmel T
    J Cardiovasc Transl Res; 2017 Aug; 10(4):359-367. PubMed ID: 28425039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphological and pharmacological determinants of peri-procedural myocardial infarction following elective stent implantation: Optical coherence tomography sub-analysis of the PRASFIT-Elective study.
    Uzu K; Shinke T; Otake H; Takaya T; Osue T; Iwasaki M; Kinutani H; Konishi A; Kuroda M; Takahashi H; Terashita D; Hirata KI; Saito S; Nakamura M; Shite J; Akasaka T
    J Cardiol; 2017 Dec; 70(6):545-552. PubMed ID: 28619235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term efficacy and safety of three different antiplatelet regimens in diabetic patients treated with primary percutaneous coronary intervention: a randomised study.
    Liu Y; Liu H; Hao Y; Hao Z; Geng G; Han W; Chen Q; Wang D; Liu L; Jia K; Zhou Y
    Kardiol Pol; 2017; 75(9):850-858. PubMed ID: 28612911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-related biomarkers and their response to inhibition with aspirin and p2y
    Lowenstern A; Storey RF; Neely M; Sun JL; Angiolillo DJ; Cannon CP; Himmelmann A; Huber K; James SK; Katus HA; Morais J; Siegbahn A; Steg PG; Wallentin L; Becker RC;
    J Thromb Thrombolysis; 2017 Aug; 44(2):145-153. PubMed ID: 28608165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.